NCT03868228View on ClinicalTrials.gov

PIPAC for the Treatment of Colorectal Peritoneal Metastases

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Colorectal NeoplasmsPeritoneal Metastases
Interventions
PROCEDURE

Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC)

Use of CapnoPen device to aerosolise Oxaliplatin 92mg/m2 chemotherapy 6-8 weekly intervals for intraperitoneal distribution via laparoscopy.

Trial Locations (1)

W2 1NY

RECRUITING

Imperial College Healthcare NHS Trust, London

Sponsors

Collaborators (1)

Barts Cancer Institute
All Listed Sponsors
collaborator

Barts Cancer Institute

OTHER

lead

Imperial College London

OTHER